Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms

(2020) Federica Raucci et al.   AUTOIMMUNITY REVIEWS

The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

(2020) P. Gisondi et al.   BRITISH JOURNAL OF DERMATOLOGY

Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients

(2020) Suxin Wan et al.   BRITISH JOURNAL OF HAEMATOLOGY

On the Alert for Cytokine Storm: Immunopathology in COVID ‐19

(2020) Lauren A. Henderson et al.   Arthritis & Rheumatology

May IL-17 have a role in COVID-19 infection?

(2020) Matteo Megna et al.   MEDICAL HYPOTHESES

Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?

(2020) Gian Marco Casillo et al.   PHARMACOLOGICAL RESEARCH

Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy

(2020) Tewodros Shibabaw   Journal of Inflammation Research

Cytokine Storm

(2020) David C. Fajgenbaum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial

(2020) Panpan Liu et al.   Trials

Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome

(2016) Roshell Muir et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE